Market revenue in 2023 | USD 175.2 million |
Market revenue in 2030 | USD 250.9 million |
Growth rate | 5.3% (CAGR from 2023 to 2030) |
Largest segment | Reagents |
Fastest growing segment | Laboratory Instruments |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Laboratory Instruments, Automated Culture System, Reagents |
Key market players worldwide | BioMerieux SA, Abbott Laboratories, BD, Danaher Corp, Hologic Inc, Roche Holding AG ADR, Bruker Corp, Bio-Rad Laboratories Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical microbiology market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 72.2% in 2023. Horizon Databook has segmented the Italy clinical microbiology market based on laboratory instruments, automated culture system, reagents covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy clinical microbiology market , including forecasts for subscribers. This country databook contains high-level insights into Italy clinical microbiology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account